New Super-Vaccine targets 24 strains of child pneumonia in first human tests
NCT ID NCT06675032
Summary
This is an early safety study testing a new pneumonia vaccine designed to protect against 24 different strains of the bacteria. It will involve 230 healthy children and teenagers, aged from 6 weeks to 17 years old. The main goal is to check if the vaccine is safe and to see how well it triggers a protective immune response in young people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIOUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Luzhou District Center for Disease Control and Prevention, Changzhi City
Changzhi, Shanxi, China
Conditions
Explore the condition pages connected to this study.